Webinar "Leveraging GeneXpert for Tuberculosis and Coronavirus testing"

LEVERAGING GENEXPERT FOR TUBERCULOSIS AND CORONAVIRUS TESTING

Now that countries with high TB burden are seeing more COVID-19, how do we test people? The TB community has invested many years in building extensive lab-networks for diagnostics, including molecular testing on GeneXpert machines. Cepheid has successfully developed cartridges to test SARS-CoV-2, which could be leveraged in TB networks and GeneXpert machines. While the TB community is actively engaging and supporting COVID-19 response in countries, there is anxiety it should not come at the cost to TB testing.

To ensure continuity of TB care, the Stop TB Partnership has published a list of points for countries to consider when selecting an appropriate SARS-CoV-2 diagnostic and deciding whether to multiplex instruments for detection of SARS-CoV-2 (Read more HERE).

Register for the Webinar HERE